binx™ health io™ System

Description

• The binx™ health io™ Instrument is the first ever 510(K), FDA-cleared, CLIA-waived, molecular point-of-care (POC) platform for chlamydia (CT) and gonorrhea (NG) detection in both males and females, enabling same-visit test and treatment
• The device is fully integrated and provides automated on-demand testing without the need for maintenance or calibration Expands access to laboratory comparable testing results in near-patient settings such as primary care offices, urgent cares, student health centers, community clinics, emergency departments, and retail pharmacies Provides the ability to test and treat within a single visit which offers improved patient outcomes such as reduced patient anxiety, lower transmission rates, fewer patients lost to follow-up, reduced empirical treatment, and less likelihood of complications or adverse events It is an easy-to-use, desktop-sized instrument that can be operated by non-laboratory trained personnel in CLIA-waived settings The device provides results comparable to a laboratory-based test for chlamydia and gonorrhea in about 30 minutes rather than days or weeks